Key Points:
- Injective inEVM Layer 2 is now launched on mainnet, enabling seamless Ethereum app deployment.
- Real-world asset-focused module integrated, offering diverse structured products.
- Enhances blockchain interoperability and drives growth in the RWA market.
Injective, after a successful testnet, announces the launch of its inEVM Layer 2 rollup solution on the mainnet, as reported by The Block.
Read more: Top 8 Notable DeFi Projects On Injective
Injective inEVM Layer 2 Solution Unveiled on Mainnet
The Injective inEVM Layer 2 launch marks a significant step in their strategy of building a network of “Electro Chains” to expand the Layer 2 ecosystem and improve blockchain interoperability.
The inEVM solution is touted as the first Ethereum Virtual Machine rollup capable of achieving true composability across Cosmos and Solana. This advancement enables Ethereum developers to deploy applications like decentralized exchanges on Injective without altering any code.
Last September, Injective collaborated with Caldera to release the inEVM testnet, enabling Ethereum applications to run seamlessly on the network. The mainnet launch, originally planned for the fourth quarter of the previous year, was delayed to ensure optimal timing for all parties involved.
Introducing Diverse Structured Products: Driving Growth in RWA Market
The update focuses on integrating a real-world asset (RWA)-focused software module, representing a significant breakthrough in the blockchain industry. This update aims to offer a range of structured products, including tokenized fiat currency pairs, treasury bonds, and private loan products, catering to both businesses and individuals.
The RWA market, although still nascent, has seen rapid growth, reflecting the demand for such products. Injective inEVM Layer 2 mainnet launch brings forth new opportunities for developers and users alike, further propelling the evolution of decentralized finance (DeFi) and blockchain interoperability.
DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing. |